CLS-015
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CLS-015, covering 2026-01-22 to 2026-01-22. Get the full timeline:
Most recent: Clinical Trial Update: Investigator Initiated Study to Assess the Safety of Combination of CLS-015 With Anti-CD-19 CAR-T Cells in Patients With Stable/Progressive Large B Cell Lymphoma at Lymphodepletion. [Phase 1]